Evidence map›Paper›PMID 35256697›Full record

ArticleScientific reports2022

Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040.

Qingwei Luo, Jie-Bin Lew, Julia Steinberg, Joachim Worthington, Xue Qin Yu, Michael Caruana, Isabelle Soerjomataram, Freddie Bray, Sheena Lawrance, Maria Arcorace and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chemopreventive Effects ofCurrent issues in molecular biology · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Qingwei LuoThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia. qingweil@nswcc.org.au.
Jie-Bin LewThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Julia SteinbergThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Joachim WorthingtonThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Xue Qin YuThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Michael CaruanaThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Isabelle SoerjomataramCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Freddie BrayCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Sheena LawranceNew South Wales Cancer Registry, Cancer Institute NSW, Sydney, NSW, Australia.
Maria ArcoraceNew South Wales Cancer Registry, Cancer Institute NSW, Sydney, NSW, Australia.
Dianne L O'ConnellThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Karen CanfellThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Eleonora FelettoThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, NSW, 1340, Sydney, Australia.
Cancer Council NSW · AUCancer Institute of New South Wales · AUCentre International de Recherche sur le Cancer · FRUniversity of Sydney · AUUniversity of Newcastle Australia · AU

Funding

World Health Organization 001
6 · The paper itself

Abstract

Previously published sub-site Australian projections for colon and rectal cancers to 2035 using the World Health Organization's mortality database sourced from the Australian Bureau of Statistics (ABS) predicted mortality rate decreases for colon cancer and increases for rectal cancer. There are complexities related to the interpretation of ABS's Australian colon and rectal cancer mortality rates, which could lead to possible inaccuracies in mortality rates for these sub-sites. The largest Australian population-wide registry, New South Wales Cancer Registry (NSWCR), compares routinely-reported causes of death with the recorded medical history from multiple data sources. Therefore, this study used the NSWCR data to project mortality rates for colon and rectal cancers separately to 2040 in Australia. The mortality rates for colon cancer are projected to continuously decline over the period 2015-2040, from 7.0 to 4.7 per 100,000 males, and from 5.3 to 3.2 per 100,000 females. Similar decreasing trends in mortality rates for rectal cancer were projected over the period 2015-2040, from 4.9 to 3.7 per 100,000 males, and from 2.6 to 2.3 per 100,000 females. These projections provide benchmark estimates for the colorectal cancer burden in Australia against which the effectiveness of cancer control interventions can be measured.

Indexed as

Colonic NeoplasmsRectal NeoplasmsAustraliaFemaleHumansIncidenceMaleMortalityRegistries

Identifiers

PMID35256697
PMCPMC8900106
OpenAlexW4221074139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.